☆ 4.7 Article

Influence of a Structured Microbiological Endotracheal Monitoring Program on the Outcome of Critically Ill COVID-19 Patients: An Observational Study

JOURNAL OF CLINICAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Review Critical Care Medicine

Ventilator-associated pneumonia among SARS-CoV-2 acute respiratory distress syndrome patients

Jacopo Fumagalli et al.

Summary: This review summarized the available evidence regarding the incidence, risk factors, and clinical characteristics of ventilator-associated pneumonia (VAP) in patients undergoing mechanical ventilation due to acute respiratory distress syndrome secondary to SARS-CoV-2 infection (C-ARDS). The majority of VAP cases were caused by Gram-negative bacteria, with occasional cases attributed to herpes virus reactivations and pulmonary aspergillosis. Potential factors driving high VAP incidence rates included immunoparalysis, prolonged ventilation, exposure to immunosuppressants, understaffing, lapses in prevention processes, and overdiagnosis.

CURRENT OPINION IN CRITICAL CARE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Bacterial Pulmonary Co-Infections on ICU Admission: Comparison in Patients with SARS-CoV-2 and Influenza Acute Respiratory Failure: A Multicentre Cohort Study

Gregoire Delhommeau et al.

Summary: This study compared the prognosis of patients admitted to an ICU for influenza pneumonia and for SARS-CoV-2 pneumonia. It found that SARS-CoV-2 pneumonia was associated with a higher risk of mortality compared to influenza pneumonia. Additionally, bacterial pulmonary co-infections on admission were not associated with patient survival rates or an increased risk of ventilator-associated pneumonia.

BIOMEDICINES (2022)

Add to Collection

Article Infectious Diseases

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Clark D. Russell et al.

Summary: Microbiologically confirmed bacterial infections are rare in patients admitted with COVID-19, mostly being secondary infections. Gram-negative organisms and S aureus are the predominant pathogens. Antimicrobial use is frequent, but can be intervened with stewardship measures.

LANCET MICROBE (2021)

Add to Collection

Article Critical Care Medicine

Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study

Anahita Rouze et al.

Summary: The incidence of ventilator-associated lower respiratory tract infections (VA-LRTI) is significantly higher in patients with SARS-CoV-2 infection compared to those with influenza pneumonia or no viral infection. Gram-negative bacilli, mainly Pseudomonas aeruginosa, Enterobacter spp., and Klebsiella spp., were responsible for a large proportion of VA-LRTI episodes.

INTENSIVE CARE MEDICINE (2021)

Add to Collection

Review Infectious Diseases

Aspergillosis: Emerging risk groups in critically ill patients

Stefan Kluge et al.

Summary: Invasive aspergillosis is a significant concern for patients in the intensive care unit, especially in those who use corticosteroids to treat underlying conditions like COPD, sepsis, or severe COVID-19. Other key risk factors include COPD, decompensated cirrhosis, liver failure, and severe viral pneumonia. Early recognition and management are crucial for preventing adverse outcomes in these patients.

MEDICAL MYCOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study

Daniele Roberto Giacobbe et al.

Summary: This study aimed to assess the incidence rate of ventilator-associated pneumonia in COVID-19 patients in intensive care units, finding that VAP is frequent and associated with a high fatality rate, likely due to the cumulative impact of the underlying viral disease and superimposed bacterial infections.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Respiratory System

Dexamethasone therapy and rates of secondary pulmonary and bloodstream infections in critically ill COVID-19 patients

Kathrin Rothe et al.

Summary: COVID-19 patients in ICUs, especially those treated with dexamethasone, are at risk of secondary infections, with respiratory pathogens being most commonly detected. Detection of bacterial superinfections was associated with worse outcomes in critically ill patients.

MULTIDISCIPLINARY RESPIRATORY MEDICINE (2021)

Add to Collection

Article Critical Care Medicine

Hospital-Acquired Infections in Critically Ill Patients With COVID-19

Giacomo Grasselli et al.

Summary: Critically ill patients with COVID-19 are at high risk for hospital-acquired infections (HAIs), especially ventilator-associated pneumonia (VAP) and bloodstream infections (BSIs) caused by multidrug-resistant organisms. HAIs prolong mechanical ventilation and hospitalization, and those complicated by septic shock nearly double mortality rate.

CHEST (2021)

Add to Collection

Article Multidisciplinary Sciences

Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study

Tobias Lahmer et al.

Summary: This study evaluated the incidence, risk factors, and outcome of invasive pulmonary aspergillosis (IPA) in critically ill patients with severe COVID-19 pneumonia. Results showed that COVID-19 was independently associated with IPA, which had a high mortality rate. Standardized screening and diagnostic approaches can aid in early detection of IPA in affected patients.

PLOS ONE (2021)

Add to Collection

Article Critical Care Medicine

Early Bacterial Identification among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Clinical Trial

Anahita Rouze et al.

Summary: The prevalence of bacterial identification within 48 hours after intubation is significantly lower in patients with SARSCoV-2 pneumonia compared to influenza pneumonia. Bacterial identification is associated with increased 28-day mortality in patients with SARS-CoV-2 pneumonia.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Critical Care Medicine

Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia

Chiagozie O. Pickens et al.

Summary: In patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation, bacterial superinfection occurs in 25% of patients at the time of intubation. Empirical antibiotic management based on guidelines leads to antibiotic overuse, while BAL-based management reduces antibiotic use significantly. VAP develops in 44% of patients and accurate identification relies on microbiologic analysis of BAL fluid.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

High sedation needs of critically ill COVID-19 ARDS patients-A monocentric observational study

Armin Niklas Flinspach et al.

Summary: Sedation therapy for severely affected COVID-19 patients requiring ventilation is challenging, with many patients needing multiple sedatives at unusually high doses. Optimal sedation strategies are still lacking in this population.

PLOS ONE (2021)

Add to Collection

Article Critical Care Medicine

Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort

Saad Nseir et al.

Summary: This study found that VAP was significantly associated with increased 28-day mortality in SARS-CoV-2 patients, but SARS-CoV-2 pneumonia did not significantly modify the relationship between VAP and 28-day mortality compared to influenza pneumonia or no viral infection.

CRITICAL CARE (2021)

Add to Collection

Article Critical Care Medicine

Ventilator-associated pneumonia in critically ill patients with COVID-19

Mailis Maes et al.

Summary: This study found that COVID-19 patients were more likely to develop VAP, with 3 cases of invasive aspergillosis identified among them and herpesvirade activation being more frequent. The causative organisms of secondary pneumonia observed were similar between COVID-19 and non-COVID-19 patients, suggesting a link to pulmonary dysbiosis caused by COVID-19.

CRITICAL CARE (2021)

Add to Collection

Review Medicine, General & Internal

Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia

Shio-Shin Jean et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Review Critical Care Medicine

Ventilator-associated pneumonia in adults: a narrative review

Laurent Papazian et al.

INTENSIVE CARE MEDICINE (2020)

Add to Collection

Article Critical Care Medicine

Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study

Charles-Edouard Luyt et al.

ANNALS OF INTENSIVE CARE (2020)

Add to Collection

Article Critical Care Medicine

Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease

Keyvan Razazi et al.

CRITICAL CARE (2020)

Add to Collection

Article Respiratory System

International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia

Antoni Torres et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Add to Collection

Review Microbiology

Viral-bacterial co-infections in the respiratory tract

Lauren O. Bakaletz

CURRENT OPINION IN MICROBIOLOGY (2017)

Add to Collection

Review Infectious Diseases

The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis

Eili Y. Klein et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2016)

Add to Collection

Article Critical Care Medicine

Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study

Ignacio Martin-Loeches et al.

LANCET RESPIRATORY MEDICINE (2015)

Add to Collection

Review Microbiology

Viral and Bacterial Interactions in the Upper Respiratory Tract

Astrid A. T. M. Bosch et al.

PLOS PATHOGENS (2013)

Add to Collection

Article Immunology

Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness

David M. Morens et al.

JOURNAL OF INFECTIOUS DISEASES (2008)

Add to Collection

Article Immunology

The 1918 influenza pandemic: Insights for the 21st century

David M. Morens et al.

JOURNAL OF INFECTIOUS DISEASES (2007)

Add to Collection

Article Critical Care Medicine

Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center

DK Warren et al.

CRITICAL CARE MEDICINE (2003)

Add to Collection

Article Critical Care Medicine

The diagnosis of ventilator-associated pneumonia using non-bronchoscopic, non-directed lung lavages

PG Flanagan et al.

INTENSIVE CARE MEDICINE (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.